Good leaders build trust which is essential to health – the foundation of prosperous economies
Medical aid schemes and businesses will help the government with the cost of acquiring enough vaccines for the South African population to achieve herd immunity
The government plans to vaccinate a minimum of 67% of the population (about 40-million people) to achieve herd immunity — when most of the population is resistant to an infectious disease — by the end of 2021.
The Bible-thumping chief justice really does seem to believe the anti-vaxxing nonsense he preaches
Financiers are ‘impact investing’ by shifting their support to investment products that prioritise environmental, social and governance issues
Equitable access to Covid-19 vaccines, therapies and diagnostics is a moral duty
France, Spain, the European Commission and Britain as well as the Bill and Melinda Gates Foundation have pledged money for equity in the treatment of Covid-19
The recent announcement of a promising Covid-19 vaccine is good news. But don’t get too excited, cautions Simon Allison: other more affluent countries have already bought up most of the doses, and we do not own the expensive technology necessary to store and transport it
As the president extends the state of disaster for another month, other restrictions will be eased, including those on alcohol sales and international travel
In the race for a safe and effective vaccine, human rights and honesty should be prioritised above profits, say activists
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it
It is imperative that we train healthcare workers and participate in continent-wide collaboration
Drug companies can be forced to ‘help’ competitors when it’s in the public interest. The WHO seeks a similar strategy for a Covid vaccine
The astronomical centre will oversee the production of cheaper and less invasive devices than ventilators to treat Covid-19 patients